HDAC3 and Familial prostate cancer: Interestingly, the steep curves of the clonogenic survival data clearly showed that both cell lines were more sensitive to RGFP966 than GDC0068 (Fig 7B and C), suggesting that prostate cancer cells are vulnerable to HDAC3 inhibition.